vs

Side-by-side financial comparison of ACNB CORP (ACNB) and NeuroPace Inc (NPCE). Click either name above to swap in a different company.

ACNB CORP is the larger business by last-quarter revenue ($47.2M vs $26.6M, roughly 1.8× NeuroPace Inc). ACNB CORP runs the higher net margin — 22.9% vs -10.3%, a 33.2% gap on every dollar of revenue. On growth, ACNB CORP posted the faster year-over-year revenue change (42.2% vs 23.9%). ACNB CORP produced more free cash flow last quarter ($52.6M vs $409.0K). Over the past eight quarters, ACNB CORP's revenue compounded faster (22.1% CAGR vs 21.1%).

ACNB Corp is a US-based financial holding company headquartered in Pennsylvania. It provides a full suite of financial solutions including retail and commercial banking, wealth management, trust services, and property & casualty insurance products. Its core market covers local communities, individual consumers, and small-to-medium enterprises across south-central Pennsylvania and northern Maryland.

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

ACNB vs NPCE — Head-to-Head

Bigger by revenue
ACNB
ACNB
1.8× larger
ACNB
$47.2M
$26.6M
NPCE
Growing faster (revenue YoY)
ACNB
ACNB
+18.3% gap
ACNB
42.2%
23.9%
NPCE
Higher net margin
ACNB
ACNB
33.2% more per $
ACNB
22.9%
-10.3%
NPCE
More free cash flow
ACNB
ACNB
$52.2M more FCF
ACNB
$52.6M
$409.0K
NPCE
Faster 2-yr revenue CAGR
ACNB
ACNB
Annualised
ACNB
22.1%
21.1%
NPCE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACNB
ACNB
NPCE
NPCE
Revenue
$47.2M
$26.6M
Net Profit
$10.8M
$-2.7M
Gross Margin
77.4%
Operating Margin
27.9%
-6.6%
Net Margin
22.9%
-10.3%
Revenue YoY
42.2%
23.9%
Net Profit YoY
63.8%
48.0%
EPS (diluted)
$1.10
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACNB
ACNB
NPCE
NPCE
Q4 25
$47.2M
$26.6M
Q3 25
$50.9M
$27.4M
Q2 25
$50.3M
$23.5M
Q1 25
$43.5M
$22.5M
Q4 24
$33.2M
$21.5M
Q3 24
$34.1M
$21.1M
Q2 24
$33.3M
$19.3M
Q1 24
$31.6M
$18.1M
Net Profit
ACNB
ACNB
NPCE
NPCE
Q4 25
$10.8M
$-2.7M
Q3 25
$14.9M
$-3.5M
Q2 25
$11.6M
$-8.7M
Q1 25
$-272.0K
$-6.6M
Q4 24
$6.6M
$-5.3M
Q3 24
$7.2M
$-5.5M
Q2 24
$11.3M
$-7.5M
Q1 24
$6.8M
$-8.9M
Gross Margin
ACNB
ACNB
NPCE
NPCE
Q4 25
77.4%
Q3 25
77.4%
Q2 25
77.1%
Q1 25
77.0%
Q4 24
75.4%
Q3 24
73.2%
Q2 24
73.4%
Q1 24
73.6%
Operating Margin
ACNB
ACNB
NPCE
NPCE
Q4 25
27.9%
-6.6%
Q3 25
37.2%
-9.5%
Q2 25
29.7%
-29.0%
Q1 25
-1.3%
-22.9%
Q4 24
24.8%
-17.0%
Q3 24
27.6%
-20.1%
Q2 24
42.8%
-32.4%
Q1 24
26.9%
-41.6%
Net Margin
ACNB
ACNB
NPCE
NPCE
Q4 25
22.9%
-10.3%
Q3 25
29.2%
-12.8%
Q2 25
23.2%
-36.8%
Q1 25
-0.6%
-29.3%
Q4 24
19.9%
-24.5%
Q3 24
21.1%
-25.9%
Q2 24
33.9%
-39.0%
Q1 24
21.4%
-49.2%
EPS (diluted)
ACNB
ACNB
NPCE
NPCE
Q4 25
$1.10
$-0.08
Q3 25
$1.42
$-0.11
Q2 25
$1.11
$-0.26
Q1 25
$-0.03
$-0.21
Q4 24
$0.77
$-0.16
Q3 24
$0.84
$-0.19
Q2 24
$1.32
$-0.26
Q1 24
$0.80
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACNB
ACNB
NPCE
NPCE
Cash + ST InvestmentsLiquidity on hand
$65.6M
$61.1M
Total DebtLower is stronger
$255.4M
Stockholders' EquityBook value
$420.0M
$19.0M
Total Assets
$3.2B
$105.6M
Debt / EquityLower = less leverage
0.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACNB
ACNB
NPCE
NPCE
Q4 25
$65.6M
$61.1M
Q3 25
$102.1M
$60.0M
Q2 25
$103.1M
$62.1M
Q1 25
$123.6M
$66.3M
Q4 24
$47.3M
$52.8M
Q3 24
$58.1M
$56.8M
Q2 24
$86.3M
$55.5M
Q1 24
$53.1M
$58.9M
Total Debt
ACNB
ACNB
NPCE
NPCE
Q4 25
$255.4M
Q3 25
$255.4M
Q2 25
$255.4M
Q1 25
$255.3M
Q4 24
$255.3M
Q3 24
$255.3M
Q2 24
$255.3M
Q1 24
$255.3M
Stockholders' Equity
ACNB
ACNB
NPCE
NPCE
Q4 25
$420.0M
$19.0M
Q3 25
$408.6M
$18.5M
Q2 25
$395.2M
$19.4M
Q1 25
$386.9M
$24.3M
Q4 24
$303.3M
$8.0M
Q3 24
$306.8M
$9.8M
Q2 24
$289.3M
$9.9M
Q1 24
$279.9M
$14.3M
Total Assets
ACNB
ACNB
NPCE
NPCE
Q4 25
$3.2B
$105.6M
Q3 25
$3.3B
$107.3M
Q2 25
$3.3B
$106.1M
Q1 25
$3.3B
$110.2M
Q4 24
$2.4B
$94.6M
Q3 24
$2.4B
$96.3M
Q2 24
$2.5B
$94.4M
Q1 24
$2.4B
$98.9M
Debt / Equity
ACNB
ACNB
NPCE
NPCE
Q4 25
0.61×
Q3 25
0.62×
Q2 25
0.65×
Q1 25
0.66×
Q4 24
0.84×
Q3 24
0.83×
Q2 24
0.88×
Q1 24
0.91×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACNB
ACNB
NPCE
NPCE
Operating Cash FlowLast quarter
$53.6M
$506.0K
Free Cash FlowOCF − Capex
$52.6M
$409.0K
FCF MarginFCF / Revenue
111.4%
1.5%
Capex IntensityCapex / Revenue
2.3%
0.4%
Cash ConversionOCF / Net Profit
4.96×
TTM Free Cash FlowTrailing 4 quarters
$92.2M
$-11.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACNB
ACNB
NPCE
NPCE
Q4 25
$53.6M
$506.0K
Q3 25
$23.2M
$-1.9M
Q2 25
$17.8M
$-2.1M
Q1 25
$-71.0K
$-7.5M
Q4 24
$39.8M
$-4.8M
Q3 24
$13.6M
$-1.7M
Q2 24
$9.7M
$-3.9M
Q1 24
$10.8M
$-7.5M
Free Cash Flow
ACNB
ACNB
NPCE
NPCE
Q4 25
$52.6M
$409.0K
Q3 25
$22.8M
$-2.0M
Q2 25
$17.6M
$-2.3M
Q1 25
$-730.0K
$-7.5M
Q4 24
$38.8M
$-4.8M
Q3 24
$13.3M
$-1.8M
Q2 24
$9.4M
$-4.0M
Q1 24
$10.7M
$-7.6M
FCF Margin
ACNB
ACNB
NPCE
NPCE
Q4 25
111.4%
1.5%
Q3 25
44.7%
-7.2%
Q2 25
35.0%
-9.6%
Q1 25
-1.7%
-33.4%
Q4 24
117.0%
-22.5%
Q3 24
39.1%
-8.7%
Q2 24
28.3%
-20.6%
Q1 24
33.9%
-42.1%
Capex Intensity
ACNB
ACNB
NPCE
NPCE
Q4 25
2.3%
0.4%
Q3 25
0.8%
0.1%
Q2 25
0.4%
0.7%
Q1 25
1.5%
0.2%
Q4 24
2.9%
0.2%
Q3 24
0.7%
0.5%
Q2 24
0.9%
0.3%
Q1 24
0.2%
0.6%
Cash Conversion
ACNB
ACNB
NPCE
NPCE
Q4 25
4.96×
Q3 25
1.56×
Q2 25
1.52×
Q1 25
Q4 24
6.03×
Q3 24
1.88×
Q2 24
0.86×
Q1 24
1.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons